This inventor holds 1 USPTO granted patent. Top assignees: Johns Hopkins University, New England Biolabs, Inc.. Active years: 2016.
Company Filing History:


Years Active: 2016
Title: Xibing Li: Innovator in Chitin Conversion Technology
Introduction
Xibing Li is a notable inventor based in Phoenix, MD (US). He has made significant contributions to the field of biotechnology, particularly in the conversion of chitin into valuable compounds. His innovative work has implications for various industries, including biofuels and pharmaceuticals.
Latest Patents
Xibing Li holds a patent for the "Conversion of chitin into N-acetylglucosamine, glucosamine and bioethanol." This patent outlines compositions and methods for converting chitin, which can be sourced from invertebrate cuticles, fungal cells, and algae, into N-acetylglucosamine, glucosamine, and ethanol. The process involves creating mutant bacteria by knocking out or inactivating specific genes, which helps maintain the chitin catabolic sensor in an activated state. Furthermore, the patent describes methods for converting N-acetylglucosamine into ethanol using a genetically engineered yeast strain, which can be co-cultivated with Vibrionaceae to achieve significant ethanol yields.
Career Highlights
Throughout his career, Xibing Li has worked with prestigious organizations, including Johns Hopkins University and New England Biolabs, Inc. His experience in these institutions has allowed him to develop and refine his innovative approaches to biotechnology.
Collaborations
Xibing Li has collaborated with esteemed colleagues, including Donald G Comb and Saul Roseman. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Xibing Li's work in the conversion of chitin into valuable compounds showcases his innovative spirit and dedication to advancing biotechnology. His contributions have the potential to impact various industries and pave the way for future research in this field.